LETTERS Concurrent Plasmodium vivax Malaria and Dengue

First Page		Document Content
Date: 2014-10-27 22:12:46 Viruses Polyomaviridae SV40 JC virus BK virus Polio vaccine Virus-like particle Virus Malaria Biology Microbiology Medicine		LETTERS Concurrent Plasmodium vivax Malaria and Dengue Add to Reading List Source URL: stacks.cdc.gov Download Document from Source Website File Size: 58,62 KB Share Document on Facebook

	The UNM Interdisciplinary HPV Prevention Center DocID: 1rtWC - View Document
	IMMUNOTHERAPIES MOVING FORWARD COMPANY Agilvax is a biotechnology company developing targeted cancer stem cell immunotherapies and vaccines for infectious diseases. The company’s DocID: 1qztD - View Document
	SUPPLEMENT ARTICLE Impact of Ebola Mucin-Like Domain on Antiglycoprotein Antibody Responses Induced by Ebola Virus-Like Particles Osvaldo Martinez,1,a Lee Tantral,1,a Nirupama Mulherkar,2 Kartik Chandran,2 and Christoph DocID: 1q28Y - View Document
	Department of Eukaryote Genetic Engineering Senior Scientist and Head Gintautas Žvirblis, PhD DocID: 1pIGC - View Document
	IMMUNOTHERAPIES MOVING FORWARD COMPANY Agilvax is a biotechnology company developing targeted cancer stem cell immunotherapies and vaccines for infectious diseases. The company’s DocID: 1ovZf - View Document